LCS
Levin Capital Strategies’s Standard BioTools LAB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-13,672
| Closed | -$26.7K | – | 277 |
|
|
2023
Q1 | $26.7K | Hold |
13,672
| – | – | ﹤0.01% | 219 |
|
|
2022
Q4 | $16K | Hold |
13,672
| – | – | ﹤0.01% | 221 |
|
|
2022
Q3 | $15K | Hold |
13,672
| – | – | ﹤0.01% | 215 |
|
|
2022
Q2 | $22K | Hold |
13,672
| – | – | ﹤0.01% | 225 |
|
|
2022
Q1 | $49K | Hold |
13,672
| – | – | ﹤0.01% | 259 |
|
|
2021
Q4 | $54K | Hold |
13,672
| – | – | 0.01% | 313 |
|
|
2021
Q3 | $90K | Hold |
13,672
| – | – | 0.01% | 294 |
|
|
2021
Q2 | $84K | Hold |
13,672
| – | – | 0.01% | 335 |
|
|
2021
Q1 | $62K | Sell |
13,672
-28,687
| -68% | -$130K | 0.01% | 321 |
|
|
2020
Q4 | $254K | Sell |
42,359
-16,383
| -28% | -$98.2K | 0.03% | 207 |
|
|
2020
Q3 | $436K | Sell |
58,742
-130,724
| -69% | -$970K | 0.06% | 147 |
|
|
2020
Q2 | $760K | Buy |
189,466
+26,878
| +17% | +$108K | 0.1% | 89 |
|
|
2020
Q1 | $413K | Buy |
162,588
+21,000
| +15% | +$53.3K | 0.07% | 96 |
|
|
2019
Q4 | $493K | Sell |
141,588
-11,841
| -8% | -$41.2K | 0.05% | 116 |
|
|
2019
Q3 | $710K | Sell |
153,429
-21,000
| -12% | -$97.2K | 0.08% | 101 |
|
|
2019
Q2 | $2.15M | Sell |
174,429
-6,427
| -4% | -$79.2K | 0.21% | 66 |
|
|
2019
Q1 | $2.4M | Sell |
180,856
-9,386,212
| -98% | -$125M | 0.27% | 55 |
|
|
2018
Q4 | $82.5M | Sell |
9,567,068
-634,723
| -6% | -$5.47M | 1.82% | 21 |
|
|
2018
Q3 | $76.4M | Sell |
10,201,791
-6,531
| -0.1% | -$48.9K | 1.31% | 24 |
|
|
2018
Q2 | $60.8M | Buy |
10,208,322
+492,914
| +5% | +$2.94M | 1.05% | 30 |
|
|
2018
Q1 | $56.7M | Buy |
9,715,408
+548,338
| +6% | +$3.2M | 1.03% | 30 |
|
|
2017
Q4 | $54M | Buy |
9,167,070
+463,310
| +5% | +$2.73M | 0.91% | 33 |
|
|
2017
Q3 | $43.9M | Buy |
8,703,760
+2,948,007
| +51% | +$14.9M | 0.74% | 34 |
|
|
2017
Q2 | $23.3M | Hold |
5,755,753
| – | – | 0.41% | 43 |
|
|
2017
Q1 | $32.8M | Hold |
5,755,753
| – | – | 0.58% | 40 |
|
|
2016
Q4 | $41.9M | Buy |
5,755,753
+1,370,490
| +31% | +$9.98M | 0.72% | 38 |
|
|
2016
Q3 | $35.1K | Buy |
4,385,263
+789,688
| +22% | +$6.33K | 0.52% | 40 |
|
|
2016
Q2 | $32.5M | Buy |
3,595,575
+1,505,320
| +72% | +$13.6M | 0.59% | 40 |
|
|
2016
Q1 | $16.9M | Buy |
+2,090,255
| New | +$16.9M | 0.31% | 57 |
|